1 |
|
Health-Related Quality of Life in Patients With Giant Cell Arteritis Treated With Tocilizumab | Vibeke Strand, Sophie Dimonaco, Katie Tuckwell, Micki Klearman, Neil Collinson, John Stone | Superior rates of sustained glucocorticoid-free remission were shown in patients with giant cell arteritis (GCA) treated with weekly (QW) or every-other-week subcutaneous tocilizumab 162 mg+26-week prednisone taper (TCZ+26) for 52 weeks compared with placebo+26-week or 52-week prednisone taper (PBO+... | 20180306_nanos_posters_216 |